LUMIBIRD And TUBIZE-FIN Have A High Dividend Yield And Return On Equity In The Healthcare Sector.

(VIANEWS) – LUMIBIRD (LBIRD.PA) is among this list of stock assets with the highest dividend rate and return on equity on the Healthcare sector.

Financial Asset Price Forward Dividend Yield Return on Equity
LUMIBIRD (LBIRD.PA) €14.60 1.25% 5.68%
TUBIZE-FIN (TUB.BR) €85.60 0.97% 4.93%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. LUMIBIRD (LBIRD.PA)

1.25% Forward Dividend Yield and 5.68% Return On Equity

Lumibird SA designs, manufactures, and sells various lasers for the scientific, industrial, and medical applications worldwide. It operates in two segments, Photonics and Medical. The company offers solid-state and diode lasers, fiber lasers, fiber lasers/amplifiers and components, Laser rangefinder and LiDAR wind doppler LiDAR, medical and ophthalmological equipment. Its products are used in various applications, such as industrial and scientific, defense and space, and lidar sensors. The company was incorporated in 1970 and is headquartered in Lannion, France.

Earnings Per Share

As for profitability, LUMIBIRD has a trailing twelve months EPS of €0.47.

PE Ratio

LUMIBIRD has a trailing twelve months price to earnings ratio of 31.06. Meaning, the purchaser of the share is investing €31.06 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.68%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend yield is 1.25%.

Volatility

LUMIBIRD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.87%, a positive 0.80%, and a positive 2.07%.

LUMIBIRD’s highest amplitude of average volatility was 2.87% (last week), 2.06% (last month), and 2.07% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, LUMIBIRD’s stock is considered to be overbought (>=80).

More news about LUMIBIRD.

2. TUBIZE-FIN (TUB.BR)

0.97% Forward Dividend Yield and 4.93% Return On Equity

Financière de Tubize SA operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium. The company is based in Brussels, Belgium.

Earnings Per Share

As for profitability, TUBIZE-FIN has a trailing twelve months EPS of €1.99.

PE Ratio

TUBIZE-FIN has a trailing twelve months price to earnings ratio of 43.02. Meaning, the purchaser of the share is investing €43.02 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.93%.

More news about TUBIZE-FIN.

Leave a Reply

Your email address will not be published. Required fields are marked *